The Taiwan-Vietnam Medical Biotechnology Industry Association held a special seminar on Taiwan-Vietnam medical biotechnology cooperation at National Taiwan University on the 27th. The event focused on discussing cooperation between Taiwan and Vietnam in the field of medical biotechnology. The purpose of this event is to promote the development of Taiwan's medical biotechnology industry in Vietnam and expand its influence in the Southeast Asian biomedical market. The meeting attracted heavyweight representatives from both Taiwan and Vietnam, including the Vietnam Economic and Cultural Office in Taipei, the Vietnam Medical Economics Association, Taipei Veterans General Hospital, Taipei Medical University, National Taiwan University Hospital, Academia Sinica, Institute for Biotechnology and Medicine Industry, Industrial Technology Research Institute, Taiwan Medical Association, Mackay Memorial Hospital, China Medical University, MinLuv Beauty Group, Delek Biomedical , Leeco Outlet Group, Leeuwenhoek Laboratories, ExoOne Bio. , GeneReach Biotechnology, PX Mart, Universal Vision Biotechnology, Quang Viet Enterprise Group, Poya International Group, Alpha Intelligence Manifolds, and others, with representatives from dozens of biomedical industry representatives, including representatives from intelligent medical industries. In addition, former Minister of Science and Technology Louis Lee, former Director of the Department of Health Twu Shiing-jer, former Minister of Health and Welfare Lin Tsou-yan, national policy advisers, and former Deputy Minister of Science and Technology Chien Chung-Liang , and other political and business leaders also attended.
Taiwan has top-notch medical professional education and research background and is leading in Asia with its comprehensive healthcare system. At this stage, the Taiwan-Vietnam Medical Association focuses on leveraging these advantages to drive Taiwan's biotech startups into the rapidly growing Vietnamese market. Over the past two years, the Taiwan-Vietnam Medical Biotechnology Industry Association has successfully assisted dozens of Taiwanese biotech companies in establishing businesses in Vietnam, expanding rapidly, and achieving significant results. These efforts have received strong support from the Taiwanese government, further promoting the investment and development of small, medium, and large enterprises in Vietnam.
With the rapid growth of Vietnam's economy and the enormous market potential brought by its population of over 100 million, Taiwan's medical biotechnology industry's layout in Vietnam not only helps improve the local medical environment but also has the potential to become a model for Taiwan's corporate internationalization. Professor Chang Wu-hsiu, chairman of the association, said, "Under the promotion of Taiwan's New Southbound Policy, the medical biotechnology industry has shown significant effectiveness. The growth potential of this industry far exceeds that of other traditional industries and is a key area worthy of government and public investment."
The Taiwan-Vietnam Medical Biotechnology Industry Association is about to hold its annual meeting, where it will showcase the development achievements of its member companies over the past two years and discuss strategies for expanding into the Vietnamese and Southeast Asian markets in the future. The association firmly believes that through continuous efforts and cooperation, Taiwan's medical biotechnology industry will achieve greater success and recognition on the international stage.
Resource (Mandarin):
